findmyKOL
Clinical trialNCT03992261CompletedPhase 4Interventional

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

SponsorMayne Pharma International Pty LtdEnrollment24Plaque Psoriasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Georgia
  • Investigative Site 9

    Batumi, Georgia

  • Investigative Site 10

    Tbilisi, Georgia

  • Investigative Site 11

    Tbilisi, Georgia

Poland
  • Investigative Site 3

    Krakow, Poland

  • Investigative Site 5

    Tarnów, Poland

  • Investigative Site 4

    Warsaw, Poland

Ukraine
  • Investigative Site 8

    Rivne, Ukraine

  • Investigative Site 6

    Uzhhorod, Ukraine

  • Investigative Site 7

    Zaporizhzhya, Ukraine

United States
  • Investigative Site 2

    Hialeah, Florida, United States

  • Investigative Site 1

    Saint Joseph, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Jun 2019
Primary completion
30 Dec 2019
Completion
30 Dec 2019
Last update posted
6 Jul 2023
Registered enrollment
24
Registry id
NCT03992261

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.